Cargando…

A revised biosynthetic pathway for the cofactor F(420) in prokaryotes

Cofactor F(420) plays critical roles in primary and secondary metabolism in a range of bacteria and archaea as a low-potential hydride transfer agent. It mediates a variety of important redox transformations involved in bacterial persistence, antibiotic biosynthesis, pro-drug activation and methanog...

Descripción completa

Detalles Bibliográficos
Autores principales: Bashiri, Ghader, Antoney, James, Jirgis, Ehab N. M., Shah, Mihir V., Ney, Blair, Copp, Janine, Stuteley, Stephanie M., Sreebhavan, Sreevalsan, Palmer, Brian, Middleditch, Martin, Tokuriki, Nobuhiko, Greening, Chris, Scott, Colin, Baker, Edward N., Jackson, Colin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6450877/
https://www.ncbi.nlm.nih.gov/pubmed/30952857
http://dx.doi.org/10.1038/s41467-019-09534-x
Descripción
Sumario:Cofactor F(420) plays critical roles in primary and secondary metabolism in a range of bacteria and archaea as a low-potential hydride transfer agent. It mediates a variety of important redox transformations involved in bacterial persistence, antibiotic biosynthesis, pro-drug activation and methanogenesis. However, the biosynthetic pathway for F(420) has not been fully elucidated: neither the enzyme that generates the putative intermediate 2-phospho-l-lactate, nor the function of the FMN-binding C-terminal domain of the γ-glutamyl ligase (FbiB) in bacteria are known. Here we present the structure of the guanylyltransferase FbiD and show that, along with its archaeal homolog CofC, it accepts phosphoenolpyruvate, rather than 2-phospho-l-lactate, as the substrate, leading to the formation of the previously uncharacterized intermediate dehydro-F(420)-0. The C-terminal domain of FbiB then utilizes FMNH(2) to reduce dehydro-F(420)-0, which produces mature F(420) species when combined with the γ-glutamyl ligase activity of the N-terminal domain. These new insights have allowed the heterologous production of F(420) from a recombinant F(420) biosynthetic pathway in Escherichia coli.